Financials

  • Market Capitalization 8.44 M
  • Employee 8
  • Founded 2011
  • CEO Paul Kang
  • Website www.exicuretx.com
  • Headquarter Delaware, United States
  • FIGI BBG00GTJCSB4
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-6.86
ratio cours/chiffre d'affaires

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
4797
TRAW
Traws Pharma, Inc. - Common Stock
0.59 USD0.00%+5.36%+20.41%-55.97%9.07 M USD
4800
IMNN
Imunon, Inc. - Common Stock
1.60 USD0.00%-1.84%-5.33%-50.77%8.98 M USD
4814
SNGX
Soligenix, Inc. - Common Stock
0.38 USD0.00%-7.32%+2.70%-66.37%8.27 M USD
4817
CNSP
CNS Pharmaceuticals, Inc. - Common Stock
5.52 USD0.00%-3.16%+13.81%-10.97%8.07 M USD

Nouvelles